← The SEC Ephemeris: the whole map
Accord Healthcare Inc. bendamustine hydrochloride
In the graph: all 7 documents (15 pages).
- Application
- NDA 216987
- Ticker
- Accord Healthcare Inc.
- Product
- bendamustine hydrochloride
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- November 6, 2025 · December 5, 2024 · May 10, 2024 · April 17, 2024 · March 7, 2024 · January 30, 2024 · April 30, 2021
From FDA letters and SEC filings. Not investment or medical advice.